Factor VIII gene therapy (Metagenomi)

N/A

Report date: 2025/11/18 09:32:47

Base Information

Drug NameFactor VIII gene therapy (Metagenomi)
Drug Alias NameMGX-001
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionCoagulation factor VIII modulatorsBlood coagulation stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMetagenomi Inc
China Registration ClassN/A

Develop Information

Active CompaniesMetagenomi Inc
Inactive CompaniesN/A
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A